MedCity News June 13, 2019
The four companies are collaborating under a program that stems from a law that Congress passed in 2013 to develop an electronic pharmaceutical tracking system.
A new initiative from a drugmaker, a retailer, a technology company and one of the four largest auditing firms will explore the use of blockchain in securing the pharmaceutical supply chain.
Under the Food and Drug Administration’s program to evaluate blockchain technology for protecting drug product integrity, Kenilworth, New Jersey-based Merck & Co., along with Walmart, IBM and KPMG, said Thursday they had been selected for the program. The purpose is to develop an electronic, interoperable system to identify and trace certain prescription drugs in the U.S.
The four companies will create a shared, permissioned blockchain network that they said would allow...